ClinicalTrials.Veeva

Menu

Aortic Stenosis Associated Left Ventricular Remodeling - An Investigation of Genetic and Gender Specific Differences in 170 Patients Undergoing Aortic Valve Replacement Surgery (SALVAGE)

L

Lisa Gundestrup

Status

Not yet enrolling

Conditions

Aortic Valve Stenosis

Study type

Observational

Funder types

Other

Identifiers

NCT05696145
SALVAGE protocol version 1

Details and patient eligibility

About

The goal of this study is to investigate the genetic and gender specific differences, in patients with low flow low gradient aortic stenosis and high flow high gradient aortic stenosis. Patients referred for surgical aorticvalve replacement will be offered to participarte in the study.

The main questions the study aims to answer are:

  1. Low-gradient aortic stenosis is associated with differences in valvular concentration of the genes that code for mast-cell chymase, Angiotensin-II, ACE, ACE2 and Angiotensin receptor 1 and 2.
  2. Low-gradient aortic stenosis is associated with differences in the genetic code of renin-angiotensin-aldosterone system.
  3. Gender differences in LV remodelling associates with different levels of sexual hormones.

Patients participating in the study will be asked to undergo:

  • Cardiac ultrasound, MR- and CT-scan prior to surgery
  • Blooddraw prior to surgery.
  • Heartmuscle biopsy during surgery
  • Cardiac MR-scan 1 year after surgery.

Enrollment

170 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Severe AS (estimated by the local heart team, aortic valve area<1cm2) referred for AVR at the cardiology department at Odense University Hospital
  2. Age > 18 years
  3. Signed informed consent

Exclusion criteria

  1. Bicuspid aortic valve.
  2. LV systolic dysfunction (LVEF<50%).
  3. Patients with concomitant moderate-severe aortic valve regurgitation.
  4. Concomitant moderate-severe mitral valve regurgitation.
  5. Moderate to severe nephropathy (s-creatinine >200 mmol/l)
  6. Unwilling to participate in the study.
  7. Claustrophobia.
  8. Permanent cardiac devices (pacemaker and ICD)

Trial contacts and locations

0

Loading...

Central trial contact

Lisa Gundestrup, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems